In light of recent studies demonstrating a role for Oct4 and Nanog in tumor progression [15], [20], this mechanistic distinction may not be exclusive to hPSCs, but more broadly applicable to multiple CSC types. This evidence concerns the gene POU5F1 and neoplasm.